Science
FDA Approves GE’s DaTscan to Detect Dementia with Lewy Bodies
GE Healthcare announced on November 3 that patients suspected of having Dementia with Lewy Bodies (DLB) now have new FDA-approved imaging options to diagnose DLB definitely. This kind of dementia is sometimes called LBD or Lewy Body Dementia. GE’s DaTscan (ioflupane I 123) has been used to confirm a diagnosis of Parkinson’s disease in over…
Read MoreACR Launches Contrast-Enhanced Mammography Screening Trial for Women with Dense Breasts
The American College of Radiology (ACR), in collaboration with the Breast Cancer Research Foundation (BCRF) and GE Healthcare, is about to launch the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST). The trial aims to ascertain whether contrast-enhanced mammography increases breast cancer detection and lowers false positives in women with dense breasts. Dense breasts account for 43%…
Read MoreThe Future of Amyloid-fighting Drugs Alzheimer’s Disease and Radiology
In the next few years, expect amyloid-fighting drugs to treat Alzheimer’s disease to be an emerging category of more commonly-used monoclonal antibodies. Researchers, led by Petrice Cogswell, MD, PhD, of the Mayo Clinic, recommend that both neuroradiologists and general radiologists become familiar with the treatment-related side effects caused by amyloid-related imaging abnormalities (ARIAs). The researchers’…
Read MoreChest CT Scans Reveal Effectiveness of Different COVID Vaccines
Emerging research about the ability of a chest CT scan to differentiate the efficacy of various COVID-19 vaccines could help dispel vaccine hesitancy. A new study, published in the American Journal of Roentgenology, highlights the critical knowledge gained from a retrospective view of chest CT scans of patients who developed COVID pneumonia. The study was…
Read More